Cargando…

Characterization of HIV-1 uncoating in human microglial cell lines

BACKGROUND: After viral fusion with the cell membrane, the conical capsid of HIV-1 disassembles by a process called uncoating. Previously we have utilized the CsA washout assay, in which TRIM-CypA mediated restriction of viral replication is used to detect the state of the viral capsid, to study the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingram, Zachary, Taylor, Melanie, Okland, Glister, Martin, Richard, Hulme, Amy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060623/
https://www.ncbi.nlm.nih.gov/pubmed/32143686
http://dx.doi.org/10.1186/s12985-020-01301-5
_version_ 1783504272092037120
author Ingram, Zachary
Taylor, Melanie
Okland, Glister
Martin, Richard
Hulme, Amy E.
author_facet Ingram, Zachary
Taylor, Melanie
Okland, Glister
Martin, Richard
Hulme, Amy E.
author_sort Ingram, Zachary
collection PubMed
description BACKGROUND: After viral fusion with the cell membrane, the conical capsid of HIV-1 disassembles by a process called uncoating. Previously we have utilized the CsA washout assay, in which TRIM-CypA mediated restriction of viral replication is used to detect the state of the viral capsid, to study the kinetics of HIV-1 uncoating in owl monkey kidney (OMK) and HeLa cells. Here we have extended this analysis to the human microglial cell lines CHME3 and C20 to characterize uncoating in a cell type that is a natural target of HIV infection. METHODS: The CsA washout was used to characterize uncoating of wildtype and capsid mutant viruses in CHME3 and C20 cells. Viral fusion assays and nevirapine addition assays were performed to relate the kinetics of viral fusion and reverse transcription to uncoating. RESULTS: We found that uncoating initiated within the first hour after viral fusion and was facilitated by reverse transcription in CHME3 and C20 cells. The capsid mutation A92E did not significantly alter uncoating kinetics. Viruses with capsid mutations N74D and E45A decreased the rate of uncoating in CHME3 cells, but did not alter reverse transcription. Interestingly, the second site suppressor capsid mutation R132T was able to rescue the uncoating kinetics of the E45A mutation, despite having a hyperstable capsid. CONCLUSIONS: These results are most similar to previously observed characteristics of uncoating in HeLa cells and support the model in which uncoating is initiated by early steps of reverse transcription in the cytoplasm. A comparison of the uncoating kinetics of CA mutant viruses in OMK and CHME3 cells reveals the importance of cellular factors in the process of uncoating. The E45A/R132T mutant virus specifically suggests that disrupted interactions with cellular factors, rather than capsid stability, is responsible for the delayed uncoating kinetics seen in E45A mutant virus. Future studies aimed at identifying these factors will be important for understanding the process of uncoating and the development of interventions to disrupt this process.
format Online
Article
Text
id pubmed-7060623
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70606232020-03-12 Characterization of HIV-1 uncoating in human microglial cell lines Ingram, Zachary Taylor, Melanie Okland, Glister Martin, Richard Hulme, Amy E. Virol J Research BACKGROUND: After viral fusion with the cell membrane, the conical capsid of HIV-1 disassembles by a process called uncoating. Previously we have utilized the CsA washout assay, in which TRIM-CypA mediated restriction of viral replication is used to detect the state of the viral capsid, to study the kinetics of HIV-1 uncoating in owl monkey kidney (OMK) and HeLa cells. Here we have extended this analysis to the human microglial cell lines CHME3 and C20 to characterize uncoating in a cell type that is a natural target of HIV infection. METHODS: The CsA washout was used to characterize uncoating of wildtype and capsid mutant viruses in CHME3 and C20 cells. Viral fusion assays and nevirapine addition assays were performed to relate the kinetics of viral fusion and reverse transcription to uncoating. RESULTS: We found that uncoating initiated within the first hour after viral fusion and was facilitated by reverse transcription in CHME3 and C20 cells. The capsid mutation A92E did not significantly alter uncoating kinetics. Viruses with capsid mutations N74D and E45A decreased the rate of uncoating in CHME3 cells, but did not alter reverse transcription. Interestingly, the second site suppressor capsid mutation R132T was able to rescue the uncoating kinetics of the E45A mutation, despite having a hyperstable capsid. CONCLUSIONS: These results are most similar to previously observed characteristics of uncoating in HeLa cells and support the model in which uncoating is initiated by early steps of reverse transcription in the cytoplasm. A comparison of the uncoating kinetics of CA mutant viruses in OMK and CHME3 cells reveals the importance of cellular factors in the process of uncoating. The E45A/R132T mutant virus specifically suggests that disrupted interactions with cellular factors, rather than capsid stability, is responsible for the delayed uncoating kinetics seen in E45A mutant virus. Future studies aimed at identifying these factors will be important for understanding the process of uncoating and the development of interventions to disrupt this process. BioMed Central 2020-03-06 /pmc/articles/PMC7060623/ /pubmed/32143686 http://dx.doi.org/10.1186/s12985-020-01301-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ingram, Zachary
Taylor, Melanie
Okland, Glister
Martin, Richard
Hulme, Amy E.
Characterization of HIV-1 uncoating in human microglial cell lines
title Characterization of HIV-1 uncoating in human microglial cell lines
title_full Characterization of HIV-1 uncoating in human microglial cell lines
title_fullStr Characterization of HIV-1 uncoating in human microglial cell lines
title_full_unstemmed Characterization of HIV-1 uncoating in human microglial cell lines
title_short Characterization of HIV-1 uncoating in human microglial cell lines
title_sort characterization of hiv-1 uncoating in human microglial cell lines
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060623/
https://www.ncbi.nlm.nih.gov/pubmed/32143686
http://dx.doi.org/10.1186/s12985-020-01301-5
work_keys_str_mv AT ingramzachary characterizationofhiv1uncoatinginhumanmicroglialcelllines
AT taylormelanie characterizationofhiv1uncoatinginhumanmicroglialcelllines
AT oklandglister characterizationofhiv1uncoatinginhumanmicroglialcelllines
AT martinrichard characterizationofhiv1uncoatinginhumanmicroglialcelllines
AT hulmeamye characterizationofhiv1uncoatinginhumanmicroglialcelllines